Published in J Antimicrob Chemother on November 20, 2007
Ciprofloxacin resistance in Neisseria meningitidis, France. Emerg Infect Dis (2008) 0.97
Phenotypic and genotypic characteristics of Neisseria meningitidis disease-causing strains in Argentina, 2010. PLoS One (2013) 0.88
Target gene sequencing to define the susceptibility of Neisseria meningitidis to ciprofloxacin. Antimicrob Agents Chemother (2013) 0.80
Determination of CEM-101 activity tested against clinical isolates of Neisseria meningitidis from a worldwide collection. Antimicrob Agents Chemother (2010) 0.78
Nalidixic acid disk for laboratory detection of ciprofloxacin resistance in Neisseria meningitidis. Antimicrob Agents Chemother (2008) 0.75
Molecular characterization of fluoroquinolone-resistant Moraxella catarrhalis variants generated in vitro by stepwise selection. Antimicrob Agents Chemother (2017) 0.75
Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment. Lancet Infect Dis (2013) 2.95
Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by the Cryotop method. Fertil Steril (2007) 1.98
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis. Antimicrob Agents Chemother (2007) 1.40
A generic mechanism in Neisseria meningitidis for enhanced resistance against bactericidal antibodies. J Exp Med (2008) 1.30
Prognostic and biologic significance of chromosomal imbalances assessed by comparative genomic hybridization in multiple myeloma. Blood (2004) 1.26
Correlation between alterations of the penicillin-binding protein 2 and modifications of the peptidoglycan structure in Neisseria meningitidis with reduced susceptibility to penicillin G. J Biol Chem (2003) 1.25
Effectiveness of meningococcal serogroup C vaccine programmes. Vaccine (2013) 1.19
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate. Antimicrob Agents Chemother (2007) 1.19
W135 invasive meningococcal strains spreading in South America: significant increase in incidence rate in Argentina. J Clin Microbiol (2009) 1.16
Capsule switching among C:2b:P1.2,5 meningococcal epidemic strains after mass immunization campaign, Spain. Emerg Infect Dis (2002) 1.13
Antigenic and/or phase variation of PorA protein in non-subtypable Neisseria meningitidis strains isolated in Spain. J Med Microbiol (2004) 1.07
New options in assisted reproduction technology: the Cryotop method of oocyte vitrification. Reprod Biomed Online (2008) 1.06
Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccines. Clin Vaccine Immunol (2012) 1.06
Emergence of high level azithromycin-resistant Neisseria gonorrhoeae strain isolated in Argentina. Sex Transm Dis (2009) 1.05
Storage of human oocytes in the vapor phase of nitrogen. Fertil Steril (2010) 0.99
Multicenter validation of a multiplex PCR assay for differentiating the major Listeria monocytogenes serovars 1/2a, 1/2b, 1/2c, and 4b: toward an international standard. J Food Prot (2005) 0.98
Sequencing of Neisseria meningitidis penA gene: the key to success in defining penicillin G breakpoints. Antimicrob Agents Chemother (2004) 0.97
New mutation in 23S rRNA gene associated with high level of azithromycin resistance in Neisseria gonorrhoeae. Antimicrob Agents Chemother (2010) 0.93
Reduced oxygen tension improves embryo quality but not clinical pregnancy rates: a randomized clinical study into ovum donation cycles. Fertil Steril (2013) 0.92
B:2a:p1.5 meningococcal strains likely arisen from capsular switching event still spreading in Spain. J Clin Microbiol (2008) 0.90
Molecular characterization of invasive serogroup Y Neisseria meningitidis strains isolated in the Latin America region. J Infect (2009) 0.90
A multi-country evaluation of Neisseria meningitidis serogroup B factor H-binding proteins and implications for vaccine coverage in different age groups. Pediatr Infect Dis J (2013) 0.89
Multicenter study for defining the breakpoint for rifampin resistance in Neisseria meningitidis by rpoB sequencing. Antimicrob Agents Chemother (2010) 0.89
Interlaboratory comparison of PCR-based methods for detection of penicillin G susceptibility in Neisseria meningitidis. Antimicrob Agents Chemother (2006) 0.88
Evaluation of the vitek 2 AST-P559 card for detection of oxacillin resistance in Staphylococcus aureus. J Clin Microbiol (2008) 0.86
Molecular epidemiology, antimicrobial susceptibilities and resistance mechanisms of Streptococcus pyogenes isolates resistant to erythromycin and tetracycline in Spain (1994-2006). BMC Microbiol (2012) 0.83
Dynamics of the penA gene in serogroup C meningococcal strains. J Infect Dis (2003) 0.83
Antibiotic resistant meningococci in Europe: any need to act? FEMS Microbiol Rev (2006) 0.82
Deletion of the Correia element in the mtr gene complex of Neisseria meningitidis. J Med Microbiol (2010) 0.80
Target gene sequencing to define the susceptibility of Neisseria meningitidis to ciprofloxacin. Antimicrob Agents Chemother (2013) 0.80
Antimicrobial susceptibility of Neisseria meningitidis strains isolated from meningitis cases in Brazil from 2006 to 2008. Enferm Infecc Microbiol Clin (2011) 0.80
Genotypes of Listeria monocytogenes strains isolated from 2000 to 2002 in Poland. Pol J Microbiol (2006) 0.80
Laparoscopy in elderly patients. Arch Esp Urol (2012) 0.79
A Case of Toxic Epidermal Necrolysis Secondary to Acetaminophen in a Child. Curr Drug Saf (2016) 0.78
Easy access to diastereomerically pure platinacycles. Chem Commun (Camb) (2004) 0.77
[Epidemiology of the meningococcal disease in Catalonia before and after vaccination against serogroup C]. Rev Esp Salud Publica (2010) 0.77
[Glycopeptide-resistant Enterococcus faecium in a hospital in northern Spain. Molecular characterization and clinical epidemiology]. Enferm Infecc Microbiol Clin (2009) 0.76
Optimizing strategies for meningococcal C disease vaccination in Valencia (Spain). BMC Infect Dis (2014) 0.76
PorB2/3 protein hybrid in Neisseria meningitidis. Emerg Infect Dis (2008) 0.75
Nalidixic acid disk for laboratory detection of ciprofloxacin resistance in Neisseria meningitidis. Antimicrob Agents Chemother (2008) 0.75
[Microbiology and public health: new challenges in surveillance and control of meningococcal disease]. Enferm Infecc Microbiol Clin (2012) 0.75
Two Cases of Neisseria meningitidis Proctitis in HIV-Positive Men Who Have Sex with Men. Emerg Infect Dis (2017) 0.75
Complications in laparoscopic renal surgery. Five year experience. Arch Esp Urol (2011) 0.75
First Cases of Severe Flaccid Paralysis Associated with Enterovirus D68 Infection in Spain, 2015-2016. Pediatr Infect Dis J (2017) 0.75
Virtual referral system between specialized endocrinological care and primary care. Endocrinol Nutr (2012) 0.75
[Neisseria meningitidis serogroup Y infection with an atypical clinical presentation and diagnosis]. Enferm Infecc Microbiol Clin (2012) 0.75
Safety and Immunogenicity of Cuban Antipneumococcal Conjugate Vaccine PCV7-TT in Healthy Adults. MEDICC Rev (2015) 0.75
[Evolution of Neisseria meningitidis sensitivity to various antimicrobial drugs over the course of chemoprophylaxis during an epidemic outbreak]. Enferm Infecc Microbiol Clin (2006) 0.75